 Mary Jesse
Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Cements | 3 | 2021 | 37 | 2.350 |
Why?
| | Spinal Fractures | 3 | 2021 | 55 | 2.300 |
Why?
| | Fractures, Compression | 2 | 2021 | 8 | 1.790 |
Why?
| | Vertebroplasty | 3 | 2021 | 8 | 1.780 |
Why?
| | Kyphoplasty | 3 | 2021 | 8 | 1.310 |
Why?
| | Joint Diseases | 2 | 2018 | 62 | 0.890 |
Why?
| | Radiculopathy | 1 | 2020 | 30 | 0.860 |
Why?
| | Hip Joint | 4 | 2019 | 108 | 0.760 |
Why?
| | Postoperative Complications | 3 | 2018 | 2097 | 0.700 |
Why?
| | Sacroiliac Joint | 1 | 2017 | 31 | 0.690 |
Why?
| | Acetabulum | 5 | 2019 | 80 | 0.690 |
Why?
| | Back Pain | 1 | 2017 | 42 | 0.690 |
Why?
| | Osteitis Deformans | 1 | 2016 | 7 | 0.670 |
Why?
| | Ankle Joint | 1 | 2018 | 136 | 0.660 |
Why?
| | Diphosphonates | 1 | 2016 | 53 | 0.640 |
Why?
| | Arthralgia | 1 | 2016 | 47 | 0.630 |
Why?
| | Femoral Fractures | 1 | 2016 | 75 | 0.630 |
Why?
| | Computer-Assisted Instruction | 1 | 2015 | 72 | 0.560 |
Why?
| | User-Computer Interface | 1 | 2015 | 161 | 0.550 |
Why?
| | Osteoporosis | 1 | 2015 | 192 | 0.520 |
Why?
| | Femoracetabular Impingement | 3 | 2019 | 34 | 0.490 |
Why?
| | Hip Dislocation | 3 | 2019 | 41 | 0.490 |
Why?
| | Education, Medical | 1 | 2015 | 222 | 0.480 |
Why?
| | Radiology | 1 | 2015 | 182 | 0.480 |
Why?
| | Diagnostic Imaging | 1 | 2013 | 277 | 0.440 |
Why?
| | Software | 1 | 2015 | 593 | 0.440 |
Why?
| | Radiography | 3 | 2018 | 863 | 0.430 |
Why?
| | Tomography, X-Ray Computed | 3 | 2019 | 2385 | 0.390 |
Why?
| | Hip Injuries | 2 | 2016 | 13 | 0.340 |
Why?
| | Retrospective Studies | 8 | 2021 | 10640 | 0.310 |
Why?
| | Tendons | 2 | 2020 | 105 | 0.240 |
Why?
| | Femur Head | 3 | 2019 | 37 | 0.230 |
Why?
| | Middle Aged | 10 | 2021 | 28539 | 0.230 |
Why?
| | Femur | 2 | 2019 | 179 | 0.210 |
Why?
| | Aged | 4 | 2021 | 19759 | 0.200 |
Why?
| | Hamstring Tendons | 1 | 2019 | 6 | 0.200 |
Why?
| | Intermittent Claudication | 1 | 2020 | 95 | 0.200 |
Why?
| | Foot | 1 | 2020 | 104 | 0.200 |
Why?
| | Female | 15 | 2021 | 61606 | 0.200 |
Why?
| | Humans | 19 | 2021 | 109171 | 0.190 |
Why?
| | Tendon Injuries | 1 | 2019 | 74 | 0.190 |
Why?
| | Treatment Outcome | 3 | 2021 | 8928 | 0.180 |
Why?
| | Running | 1 | 2020 | 219 | 0.180 |
Why?
| | Aged, 80 and over | 3 | 2021 | 6709 | 0.170 |
Why?
| | Femur Head Necrosis | 1 | 2016 | 11 | 0.170 |
Why?
| | Arthrography | 1 | 2016 | 22 | 0.170 |
Why?
| | Magnetic Resonance Imaging | 5 | 2019 | 2913 | 0.170 |
Why?
| | Prevalence | 2 | 2020 | 2329 | 0.170 |
Why?
| | Syndrome | 1 | 2017 | 339 | 0.170 |
Why?
| | Osteoarthritis, Hip | 1 | 2016 | 35 | 0.160 |
Why?
| | Muscle Neoplasms | 1 | 2016 | 8 | 0.160 |
Why?
| | Evoked Potentials, Motor | 1 | 2016 | 33 | 0.160 |
Why?
| | Bone Density Conservation Agents | 1 | 2016 | 56 | 0.160 |
Why?
| | Monitoring, Intraoperative | 1 | 2016 | 54 | 0.160 |
Why?
| | Male | 10 | 2021 | 60174 | 0.160 |
Why?
| | Peripheral Arterial Disease | 1 | 2020 | 250 | 0.160 |
Why?
| | Peripheral Nerve Injuries | 1 | 2016 | 37 | 0.160 |
Why?
| | Hip Dislocation, Congenital | 1 | 2015 | 26 | 0.150 |
Why?
| | Myelography | 1 | 2014 | 7 | 0.150 |
Why?
| | Epidural Space | 1 | 2014 | 8 | 0.150 |
Why?
| | Cryosurgery | 1 | 2016 | 56 | 0.150 |
Why?
| | Spinal Nerve Roots | 1 | 2014 | 35 | 0.150 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2016 | 93 | 0.150 |
Why?
| | Intraoperative Complications | 1 | 2016 | 123 | 0.150 |
Why?
| | Diagnosis, Differential | 2 | 2016 | 1459 | 0.150 |
Why?
| | Fibrocartilage | 1 | 2013 | 5 | 0.140 |
Why?
| | Bone Neoplasms | 1 | 2016 | 193 | 0.140 |
Why?
| | Ligaments, Articular | 1 | 2013 | 49 | 0.130 |
Why?
| | Patient Positioning | 1 | 2013 | 50 | 0.130 |
Why?
| | Spinal Cord Injuries | 1 | 2014 | 135 | 0.130 |
Why?
| | Femoral Artery | 1 | 2013 | 162 | 0.120 |
Why?
| | Cohort Studies | 1 | 2020 | 4804 | 0.110 |
Why?
| | Cartilage, Articular | 1 | 2013 | 264 | 0.100 |
Why?
| | Case-Control Studies | 1 | 2017 | 3324 | 0.100 |
Why?
| | Adnexal Diseases | 1 | 2008 | 3 | 0.100 |
Why?
| | Gadolinium DTPA | 1 | 2008 | 49 | 0.090 |
Why?
| | Cysts | 1 | 2008 | 84 | 0.090 |
Why?
| | Pelvic Neoplasms | 1 | 2007 | 23 | 0.090 |
Why?
| | Abdominal Neoplasms | 1 | 2007 | 37 | 0.090 |
Why?
| | Thoracic Neoplasms | 1 | 2007 | 36 | 0.090 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2007 | 54 | 0.080 |
Why?
| | Renal Insufficiency | 1 | 2008 | 119 | 0.080 |
Why?
| | Skin Diseases | 1 | 2008 | 166 | 0.080 |
Why?
| | Contrast Media | 1 | 2008 | 386 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1359 | 0.070 |
Why?
| | Tenotomy | 1 | 2020 | 13 | 0.050 |
Why?
| | Tendon Transfer | 1 | 2020 | 46 | 0.050 |
Why?
| | Decompression, Surgical | 1 | 2020 | 90 | 0.050 |
Why?
| | Hamstring Muscles | 1 | 2019 | 12 | 0.050 |
Why?
| | Adult | 6 | 2019 | 31455 | 0.050 |
Why?
| | Physical Endurance | 1 | 2020 | 264 | 0.050 |
Why?
| | Biomechanical Phenomena | 1 | 2020 | 668 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2015 | 1931 | 0.040 |
Why?
| | Range of Motion, Articular | 1 | 2019 | 380 | 0.040 |
Why?
| | Arthroplasty | 1 | 2016 | 51 | 0.040 |
Why?
| | Recovery of Function | 1 | 2020 | 607 | 0.040 |
Why?
| | Image Enhancement | 1 | 2016 | 176 | 0.040 |
Why?
| | Osteotomy | 1 | 2016 | 149 | 0.040 |
Why?
| | Postoperative Care | 1 | 2016 | 273 | 0.040 |
Why?
| | Observer Variation | 1 | 2015 | 341 | 0.040 |
Why?
| | Adolescent | 3 | 2020 | 18208 | 0.030 |
Why?
| | Young Adult | 2 | 2016 | 10686 | 0.030 |
Why?
| | Endometriosis | 1 | 2008 | 30 | 0.020 |
Why?
| | Pregnancy, Ectopic | 1 | 2008 | 48 | 0.020 |
Why?
| | Gestational Trophoblastic Disease | 1 | 2007 | 5 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 2840 | 0.020 |
Why?
| | Teratoma | 1 | 2008 | 89 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2008 | 407 | 0.020 |
Why?
| | Pregnancy | 2 | 2008 | 5006 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 3985 | 0.020 |
Why?
| | Fibrosis | 1 | 2008 | 385 | 0.020 |
Why?
| | Renal Dialysis | 1 | 2008 | 304 | 0.020 |
Why?
| | Ovarian Neoplasms | 1 | 2008 | 328 | 0.020 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2007 | 223 | 0.020 |
Why?
| | Biopsy | 1 | 2008 | 1082 | 0.020 |
Why?
| | Kidney Neoplasms | 1 | 2007 | 311 | 0.020 |
Why?
| | Liver Neoplasms | 1 | 2007 | 481 | 0.020 |
Why?
| | Melanoma | 1 | 2007 | 684 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2007 | 1829 | 0.010 |
Why?
| | Risk Factors | 1 | 2008 | 8786 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2007 | 2151 | 0.010 |
Why?
|
|
Jesse's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|